In gastric cancer, a risk signature was constructed using 3 m6A RNA methylation regulators (FTO, RBM15, and ALKBH5), which not only was an independent prognostic marker but could also predict the clinicopathological features of gastric cancer [25]. This evidence concerns the gene ALKBH5 and gastric cancer.